Precision management of radiotherapy interruption in locoregionally advanced nasopharyngeal carcinoma: Induction chemotherapy counteracts the survival impact in high-risk patients defined by a novel model
The developed model effectively identified high-risk NPC patients vulnerable to RTI ≥5 days, with IC shown to mitigate this risk. These findings support the implementation of risk-stratified treatment strategies and proactive IC use to counter unavoidable treatment delays.
Authors
- Yue Yao (ORCID: https://orcid.org/0000-0002-9333-1559)
- Wenkui Li (ORCID: https://orcid.org/0000-0002-1739-9957)
- Zhong-Guo Liang
- Li-ting Ling
- Jing-wen Cheng
- Qing-qing Nong
- Xue-wen Luo
- Ying Guan
- Ling Li
- Song Qu
- Ye (Lennon) Li
- Xiao-dong Zhu
- Bo-lin Zhu
- Min Bi
- Li-Qing Zhou
- Bin Deng
- Fang Su
Institutions
- Guangxi Medical University (CN)
- Guangxi Zhuang Autonomous Region Health and Family Planning (CN)
- Wuzhou Red Cross Hospital (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1016/j.tranon.2026.102725
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00